JPRN-UMIN000026319尚未招募未知
The intervention trial of safety and efficacy of once-weekly Trelagliptin switched from daily DPP4 inhibitors for elderly patients with type 2 diabetes - Safety and efficacy of Trelagliptin in elderly patients with type 2 diabetes
Kanagawa-ken Keiyu-kai Keiyu hospital0 个研究点目标入组 30 人开始时间: 2017年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with renal dysfunction [creatinine clearance <50 ml/min or serum creatinine above 1.4 mg/dl(male), 1.2 mg/dl(female)] Patients using insulin or GLP-1 receptor agonists
研究者
相似试验
已完成
不适用
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastasesJPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
进行中（未招募）
1 期
A randomized study of the efficacy and safety of OncoGel™ treatment as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation prior to surgery in subjects with localized or loco-regional esophageal cancerlocalized or loco-regional esophageal cancerMedDRA version: 9.1Level: LLTClassification code 10015362Term: Esophageal cancerEUCTR2007-005051-42-BEProtherics Salt Lake City, Inc124
进行中（未招募）
不适用
A randomized study of the efficacy and safety of OncoGel™ treatment as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation prior to surgery in subjects with localized or loco-regional esophageal cancerlocalized or loco-regional esophageal cancerMedDRA version: 9.1Level: LLTClassification code 10015362Term: Esophageal cancerEUCTR2007-005051-42-CZProtherics Salt Lake City, Inc156
未知
3 期
Clinical study to assess the efficacy and safety of TA-650 in patients with active ulcerative colitisJPRN-jRCT2080220293Mitsubishi Tanabe Pharma Corporation
已完成
3 期
Clinical Trial of S-Amlodipine , Olmesartan and Hydrochlorothiazide combination tablet in the treatment of HypertensioCTRI/2011/06/001820Emcure Pharmaceuticals Ltd Pune200